Genentech’s Avastin cancer drug appears to treat age-related macular degeneration as safely as Genentech’s drug Lucentis, which is approved for that condition and costs significantly more, a new analysis says. The findings, published Monday, are the latest to suggest that Avastin can be used off-label and safely for age-related macular degeneration, the leading cause of legal blindness in elderly populations of industrialized countries. In this case, the researchers judged safety on whether the medicines resulted in deaths or serious side effects that result in death, are life-threatening, require hospital admission or prolong hospital stay, or cause disability. In a controversial move this summer, Italy decided to reimburse patients who are given Avastin for age-related macular degeneration — a move that could encourage more doctors to prescribe it off-label.

Topics:  genentech s avastin   lucentis   italy   genentech s   avastin   in   drug   age-related   macular   degeneration   move   off-label   safely   hospital   
BING NEWS:
  • Cholesterol-lowering drug slows progression of eye disease in people with diabetes: Clinical trial
    The LENS trial has demonstrated that fenofibrate, a drug usually used to lower cholesterol, reduces the risk of progression of diabetic retinopathy by 27%. The results were announced at the American ...
    06/24/2024 - 1:53 am | View Link
  • Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
    --(BUSINESS WIRE)--Genentech ... if Columvi is safe and effective in children. The conditional approval of Columvi is based on response rate and durability of response. There are ongoing studies to ...
    06/14/2024 - 11:00 pm | View Link
  • Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
    Italy’s antitrust regulator has initiated an investigation into several pharmaceutical giants, including Novartis AG (NYSE:NVS) and Roche Holdings AG (OTC:RHHBY)-controlled Genentech, for allegedly ...
    06/6/2024 - 6:19 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News